chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt received covid shot.  waited around the 15 minutes after and girlfriend reported that he fainted in the aisle.  He had a gash on his scalp and said he fainted.  We put in in a chair with legs raised.  took bp and hr.  all were normal.  pt reported he was still feeling faint and flushed so we called the emt.  amubulance and fire truck came.  pt reported feeling better and refused medical care.
She's been itchy every since; Roughness coming up; Rash coming up; This is a spontaneous report from a non-contactable nurse (Other HCP) (patient's mother). A 17-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiry date: unknown) via an unspecified route of administration on 08Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 10Apr2021, the patient experienced she's been itchy every-since, roughness coming up and rash coming up. Caller states, her daughter got the first Pfizer vaccine on 08Apr2021, she has been itchy every-since, this started 2 days later. Caller spoke to her doctor and he said it's probably a reaction to vaccine. Her daughter has no rash, just itchy skin, the only difference today was it looks like or has roughness or rash coming up. Dermatologist says it's probably from her scratching, and says it makes sense that it's probably the vaccine. The way it looks, he didn't feel it would be a problem to get the second dose, since it occurred 2 days later. Caller asked, was it recommend to get the second dose. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Dizziness  20 lb weight loss, Lethargy  Narrative:  Employee relates onset of dizzy spells, loss of energy and 20 lb weight loss since second immunization. Employee encouraged to see out medical care at Urgent Care due to lack of PCP.
I developed a severe neuropathic itch that has been hard to treat. It's awful! The Dr.s have had me try capsicum, lidocaine and nortriptyline with no luck. I wish I had never received this shot. It's a daily itch that can get really intense. The shot has caused me nerve damage instead of protecting me. I've been treated by both my primary Dr. and Dermatologist for this,
10:05am, Dizzness, nausea, tinnitus, tightening in chest, trouble swallowing, raised blood pressure, sniffed alcohol pads, drank Gatorade, refused 911 call.  Tinnitus is still ongoing an present at time of report 6:23p
No adverse responses to vaccine at this time. First vaccine was received on 08/30/21. The second  vaccine was received 09/23/2021 by  RN. Currently this person in not exhibiting any adverse effects, no necessary treatment at this time, but will continue to monitor for a positive patient outcome.
Fever, erythema & swelling at injection site on (L) thigh developed 8 days post vaccination with fine papular rash developing on trunk day 8-9. Child otherwise well.
Tested positive for covid-19; Bad chills; Fever; Tired; Pain in the arm where she got the injection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid-19) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ORAL CONTRACEPTIVE NOS for an unknown indication.    On 07-Jan-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced COVID-19 (tested positive for covid-19). At the time of the report, COVID-19 (tested positive for covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: On 14 Jan 2021, due to the COVID-19 symptoms, patient took the test and tested positive. Patient wanted to know whether this will affect her ability to get the second shot On 04-Jun-2021: Non-significant follow-up appended.
Patient called stating she had a welt in the area the vaccinations were given.  She noticed it on 10/5/23.  Welt is approximately 2 to 3 inches in diameter.  Does not itch and is not irritated or burning.  Patient states it is not really bothering her and will contact her primary care doctor tomorrow (too late to reach md tonight).  Not sure of outcome with provider since patient has not contacted them yet.
Loss of consciousness, followed by fever, and inability to urinate and leg weakness that persists to this day. Diagnosis is transverse myelitis.
Heart fluttering; more extreme exhaustion; Discomfort; sore arm; Heart fluttering; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Mar-2021 and was forwarded to Moderna on 18-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of the first episode of CARDIAC FLUTTER (Heart fluttering) and the second episode of CARDIAC FLUTTER (Heart fluttering) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2020, the patient experienced PYREXIA (Fever). On 12-Feb-2021, the patient experienced the first episode of CARDIAC FLUTTER (Heart fluttering) (seriousness criterion medically significant), FATIGUE (more extreme exhaustion), DISCOMFORT (Discomfort) and VACCINATION SITE PAIN (sore arm). On 13-Mar-2021, the patient experienced the second episode of CARDIAC FLUTTER (Heart fluttering) (seriousness criterion medically significant). At the time of the report, last episode of CARDIAC FLUTTER (Heart fluttering) outcome was unknown, FATIGUE (more extreme exhaustion) had resolved, DISCOMFORT (Discomfort) and VACCINATION SITE PAIN (sore arm) was resolving and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 103.3 (High) Fever for 103.3 degree.         This case concerns a 43 Y/O M with a serious unexpected event of cardiac flutter and non-serious expected pyrexia.  Event onset on Day 2 after second dose mRNA-1273. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Treatment medications included ibuprofen and acetaminophen.; Sender's Comments: This case concerns a 43 Y/O M with a serious unexpected event of cardiac flutter and nonserious expected pyrexia.  Event onset on Day 2 after second dose mRNA-1273. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initial report received from a consumer who is also the patient on 11 JANUARY 2013. A 29-year-old male patient, who had medical history of allergies to bee sting and seasonal allergies and had no other history of medical conditions, had received an intramuscular dose of FLUZONE (batch number-unknown) at right deltoid on 16 DECEMBER 2012. The patient had no illness at the time of vaccination. On 19 DECEMBER 2012 (within 72 hours of the vaccination) the patient experienced itchy palms. About 1 week later the patient experienced red spots rash on palms, spread to wrists, collar bone, and then all over body. The patient continued to have breakout of raised, swollen, itchy, red patches. On an unspecified date, own PCP diagnosed as erythema multiform. The patient required ER/Doctor visit. Corrective treatment and laboratory investigations were not reported. At the time of this report, the patient's outcome was not recovered. Documents held by sender: None.
Injection site pain; Swelling Initial and follow up information has been received from a licensed practical nurse concerning a 60 year old white female with arrhythmia. hormone replacement therapy, no known allergies an a prior immunization with pneumococcal 23v polysaccharide vaccine in 2000. On 26-OCT-2005, the patient was vaccinated intramuscularly into the left arm with pneumococcal 23v polysaccharide vaccine (Lot #651526/0604R). On that same day in the AM the patient was vaccinated intramuscularly into the right arm with the fourth dose of influenza virus split virion 3v vaccine inactivated (Fluzone) (influenza virus split virion 3v vaccine inactivated) (Lot #U1777AA). Concomitant therapy included verapamil, estrogens, conjugated (Premarin) and digoxin (Lanoxin). On 26-OCT-2005 in the PM the patient developed "extremely painful muscle at the injection site" and "some swelling x4days". On 30-OCT-2005 the patient recovered from the events. Additional information is not expected.
A report was received from a health care professional on 19 November 2003, concerning a 49 year old female vaccinee who experienced angioedema which was considered to be medically significant (OMIC) the day after inadvertently receiving Fluvirin intradermally on 14 November 2003. The vaccinee had an allergy to co-trimoxazole and has no concomitant medications. On 15 November 2003 the vaccinee experienced angioedema with generalized urticaria and swelling of the lips and tongue after inadvertently receiving Fluvirin intradermally. The vaccinee was treated with diphenhydramine. At the time of the report the angioedema was improved nut continuing. There was insufficient information to determine the reporter's causality assessment. Follow-up pending. See ref: PJP-2003-01116.
Took second dose of Vivotif on day 4; A spontaneous report was received from the pharmacist on 23AUG2022. It described a male patient (unknown age) who "took second dose of Vivotif on day 4" (PT: Inappropriate schedule of product administration). The patient took the Vivotif capsule (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient started his Vivotif regimen on 19AUG2022, and instead of taking the next dose on 21AUG2022, he took it on 22AUG2022. The outcome of the reported event was not applicable.  Action taken with Vivotif with respect to the reported event was not applicable.  No additional information was reported.  Company comment: It was reported that a patient took the second dose of Vivotif on day 4 (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a patient took the second dose of Vivotif on day 4 (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non serious as per medical assessment.
Moderna COVID?19 Vaccine  Acute appendicitis, non-perforated. Required emergency surgery(appendectomy)
Patient experienced swelling, blisters, warmth to touch, fever. Patient said that at home she popped one of the blisters with a needle, that she sterilized. She was then treated for cellulitis. Given cephalexin 500mg 1 capsule twice daily x 7 days.
Covid-type headache unrelieved with tylenol or ibuprofen lasting greater than 12 hours. We finally gone when i got up the next day. Fatigue and loss of appetite until following morning.
Reports redness on the left cheek few minutes after the vaccine.  Denies chest pain, SOB, itching, blurred vision. BP: 121/75 HR: 81 Sp02: 100% T: 97.3  seen and cleared by EMS
Injection into left arm, pt has had pain and discomfort since, irritating per pt reports. Impacting sleep and cannot sleep on arm, notices discomfort when moving arm. No issues with 2nd dose if right arm.
Pt c/o flu like symptoms- subjective fevers, malaise with body aches and headache started yesterday associated with nausea and non bloody and nonb ilious vomiting so came to ER. On arrival pt found to have hypoxic dx w/ COVID-19 pna; tx w/ O2, steroids, zinc, abx; weaned to RA for home dc.
Rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced rash. The patient was treated with prednisone. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was not reported. The pharmacist called to report that the patient has rash. The patient was scheduled for 2nd dose of Shingrix. Doctor gave Shingrix and prednisone for the rash.  The reporter stated that she did not have Shingles.  The reporter consented to follow up.
MS flare up happened a few days after vaccine. Full blown MS exacerbation within a week and off work 4/29/2019 for 4 weeks. Unable to walk, care for myself, optic neuritis causing permanent vision problems.
No adverse event.  Reporting due to administrated Pfizer vaccine to an 11 year old on accident.  We were having a school clinic and I did not note the  age correctly.  Thought the client was 12.
On 9/23/03, child's aunt went to bedroom at 08:30 to awaken child. Not in her bed. Passed out on sofa next to door. Child was difficult to wake, very withdrawn, sleepy, lethargic, no eating, wants to drink. Advised to take child to ER immediately. D/C Summary received which revealed patient hospitalized from 9/23//03 to 9/25/03 w/dx hypoglycemia & hypotension.
Chills, fatigue, body aches, headache, nausea, numb fingers and lips, and pain in the arm that injected
The patient received the wrong immunization; he was scheduled to receive the Pfizer-BioNTech COVID19 Bivalent Updated Booster vaccination, but received a dose of the Pfizer-BioNTech COVID19 Primary Series immunization by mistake. I discovered the error on 4/7/23 and informed the patient of the error the same day. He did not report any adverse events. I apologized to the patient for the mistake and informed him we would be receiving the Pfizer-BioNTech COVID19 Bivalent Updated Booster later on that day and if appropriate/if he was available we could administer the correct vaccine. He appreciated informing him of the error, however he informed that he was not available. I advised him we would verify the appropriate next steps and keep him updated of the situation.
Full night of fever/chills 36 hours after vaccine, 3 days of severe exhaustion starting 24 hours after vaccine
This case was reported by a healthcare professional (certified medical assistant) and described the occurrence of abscess on genital area in a 1-year-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included haemophilus influenzae type b vaccine (non-gsk); non-GSK manufacturer; unknown; unknown given on 13 August 2013; pneumococcal vaccines (non-gsk); non-GSK manufacturer; unknown; unknown given on 13 August 2013. On 13 August 2013 the subject received a dose of KINRIX (.5 ml, unknown route, unknown deltoid) as the 3rd dose in the DTaP and IPV series and experienced inappropriate age at vaccine administration. Per the reporter, the subject was "inadvertently administered" KINRIX. The subject was younger than the indicated age for KINRIX. KINRIX is indicated to be used as the fifth dose in the DTAP and the fourth dose in the IPV series. On 13 August 2013, 2 days after vaccination with KINRIX, the subject experienced abscess on genital area. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
wheezing, retractions occurred the next morning. this is the patient's first time with wheezing.
Headache starting 20min after injection. Fatigue and tiredness starting within an hour.  Dizziness starting within 2 hours
She has not had a period after receiving her third vaccine.  It's been ten months since she had a period.4/2/09-records received for DOS 3/17/09-office visit 25 pound weight gain since 8/08-last period 8 months ago.
Patient has a plastic aortic valve and has a home INR monitor to help her monitor her INR.  The morning of the vaccination her INR was 3.6.  She got the vaccine and later started to feel exhausted, malaise, and "like she was dying." When her blood is not anticoagulated enough it cannot pass through her valve as easily and she feels miserable she said.  She checked her INR the following morning and it was 2.6.  She talked to her cardiologist and they suggested she take an additional 2.5mg of warfarin that morning.  She started to feel better relatively quickly.
Itching, blister like rash around the injection site. Pain in arm for extended period.
This spontaneous report was received from a public health nurse referring to an ubnknown number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with incorrect storage dose of LIQUID PEDVAXHIB for prophylaxis (strength, dose, route, frequency, indication, lot/batch # and expiration date were not reported). The reporter had no knowledge of whether any patients had any adverse effects after receiving the vaccine. It was stated that the vaccines underwent a temperature excursion of 12.5  degrees Celsius for 6 hours 54 minutes. Previous temperature excursion were not reported. The call was because of a "data logger". No further information was provided. Additional information has been requested.
1200 c/o dizziness; 1300 rt leg started to tingle, hot & cold flashes; 1540 discharged from ER cont to have sx diaphoretic, dizzy (sl);
Skin color pale, lips pale. Complained of "feeling funny". Diminished hearing; diaphoretic. No SOB. RAS 106/50; 10 minutes later, RAS 104/56. P-60 R; 10 minutes later, P 64 Reg. Lasted 10 minutes. Client had eaten.
fever of 101; Sick; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Covid vaccine (had covid vaccine in March 2021).   In September 2021, the patient received the 1st dose of Shingles vaccine. In September 2021, less than a week after receiving Shingles vaccine, the patient experienced fever and sickness. On an unknown date, the outcome of the fever and sickness were recovered/resolved.   It was unknown if the reporter considered the fever and sickness to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient got shingles shot and felt sick for a couple days with a fever of 101 degree F. The patient stated that well worth it. The patient also took covid vaccine in March 2021. The patient stated that one more shingles shot in December. The contact details was not reported hence follow up not possible.
This spontaneous report was received from a medical assistant, referring to a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with and incorrect stored dose of M-M-R II lot # N001532 with expiration date on 13-JAN-2019 (strength and route were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 47 Fahrenheit grades range for a time frame of 1 hour and 15 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 49-year-old male patient received BNT162b2 (BNT162B2), on 16Aug2021 as dose 1, single (Lot number: FC3180) at the age of 48 years for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "has just fallen apart, his body has fallen apart"; ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "he did get sick but it was not too bad". Additional information included: This report was not related to a study or program. PRODUCT DETAILS: NDC, Expiration date unknown. Unknown which arms he got them in. Second dose administered on 07Sep2021, LOT- FC3181. Caller says his first dose he did get sick but it was not too bad. He says the second dose he got really sick and had the issues to his whole body which he continues to have problems.
Terrible headache of intense internal pressure that started day 5 and lasted 8 days! Very little relief from otc meds.
On 10/14/21 I experienced an episode of vaginal bleeding. I have been post menopausal for 3years.  I made an appointment with my doctor on 10/20/21, at that time it was only one event, but she had me schedule an ultrasound. Approximately 2 days later I started light vaginal bleeding and it has continued since. Not like having a period just a light bleeding.  A couple of years ago I had benign polyps removed, and was thinking those had returned, although I?ve had no problems for 2 years, and hadn?t thought about reporting the bleeding. However, during my last VSafe check in, it recommended if you have seen a doctor for anything since your vaccination it should be reported, so I did. A person from the CDC contacted me and said that I should report this issue via VAERS.
Tinnitus. I was asleep when I started hearing high pitch sounds. It stopped after a few seconds and after a few days later I had another loud burst of high pitch sounds. Since then I have a high pitch hissing sound on my ears. It?s been 4 months. I can't sleep.